Soy Isoflavones - Mounting Evidence in Breast Cancer Prevention

September 14, 2004

Researchers from the Department of Nutrition, University of South Florida College of Medicine in Tampa state that it is evident that Isoflavones are promising agents for breast cancer prevention. This is based on evidence from epidemiological, animal, in vitro data, and human clinical trials. The researchers review current evidence and state it is time to start major clinical studies to prove the value of soy Isoflavones, the dosage needed, timing and duration of exposure for best results. The analysis is published in the September 2004 issue of Frontiers in Bioscience.

Coenzyme Q10 is Low in Coronary Artery Disease Patients

Coenzyme Q10 is recognized as protective and decreasing the risk of coronary artery disease (CAD). In this study 64 CAD patients had their coenzyme Q10 levels compared to those of 34 healthy adults. The CAD patients had lower ratios of coenzyme Q10 to LDL-cholesterol than healthy individuals. The study is published in the August 2004 issue of the journal Clinical Biochemistry.

Saw Palmetto Great for Symptoms of Swollen Prostate

Researchers from the University of Chicago Medical School examined a cross section of clinical trials and have come to the conclusion that Saw Palmetto Berry extract is useful as a first line of treatment for managing lower urinary tract symptoms in benign prostatic hyperplasia. The study is published in the August 2004 issue of the British Journal of Urology.

SAMe Reconsidered

In the January 2001 issue of the Harvard Mental Health Letter, Harvard experts noted that the evidence for SAMe, a nutrient increasingly used for depression, was inconclusive. In the time since here have been further developments and a government-funded panel, which conducted an analysis of the scientific literature, reported that SAMe is probably as effective as conventional antidepressants for treating depression. And now in this update on the use of the supplement SAMe for depression; the Harvard specialists say that New Research points to SAMe actually being as effective as antidepressants. The report appears in the January 2004 issue of the Harvard Mental Health Letter.